Inovio Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.12.24	Inovio Pharmaceuticals Prices $30 Mln Public Offering With Warrants (RTTNews)
03.12.24	INOVIO Reports Data From Retrospective Trial Evaluating INO-3107 - Quick Facts (RTTNews)
14.11.24	Inovio Pharmaceuticals Inc. Q3 Loss Narrows (RTTNews)
08.08.24	Inovio Pharmaceuticals Inc. Q2 Loss Decreases (RTTNews)
13.05.24	Inovio Pharmaceuticals Inc. Q1 Loss Declines (RTTNews)
16.04.24	Inovio Announces Pricing Of About $36 Mln Offering Of Stock And Pre-Funded Warrants; Stock Drops (RTTNews)
06.03.24	Inovio Pharmaceuticals Inc. Q4 Loss Narrows (RTTNews)
04.01.24	INOVIO Enters Clinical Collaboration And Supply Agreement With Coherus BioSciences (RTTNews)
03.01.24	INOVIO Plans To Submit BLA For INO-3107 In H2 - Quick Facts (RTTNews)
09.11.23	Inovio Pharmaceuticals Inc. Q3 loss drops in line with estimates (RTTNews)
10.10.23	Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP (RTTNews)
07.09.23	INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15% (RTTNews)
09.08.23	Inovio Pharmaceuticals Inc. Q2 Loss decreases, beats estimates (RTTNews)
23.06.23	INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions (GlobeNewswire)
24.05.23	Inovio : EU Grants Orphan Drug Designation For INO-3107 (RTTNews)
10.05.23	Inovio Pharmaceuticals Inc. Q1 Loss decreases, but misses estimates (RTTNews)
26.04.23	INOVIO: COMP Issues Positive Opinion For Orphan Drug Designation In The EU For INO-3107 (RTTNews)
17.04.23	Inovio Presents Data From Phase 1b Trial With INO-4201 As Ebola Booster For RVSV-ZEBOV (RTTNews)
01.03.23	Inovio Pharmaceuticals Inc. Q4 Loss decreases, but misses estimates (RTTNews)
02.02.23	INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201 (RTTNews)
31.01.23	INOVIO Announces 11% Headcount Reduction (RTTNews)
08.11.22	Inovio Pharmaceuticals Inc. Q3 Loss decreases, beats estimates (RTTNews)
13.10.22	INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis (RTTNews)
19.09.22	Pre-market Movers: BCAN, REUN, FOXO, ETNB, INO… (RTTNews)
09.08.22	Inovio Pharmaceuticals Inc. Q2 Loss increases, misses estimates (RTTNews)
19.07.22	INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses (RTTNews)
01.07.22	Pre-market Movers: INO, CLSK, BORR, KSS, HNRG… (RTTNews)
19.05.22	Pre-market Movers: CIG, NOVN, INO, BGXX, CSCO… (RTTNews)
11.05.22	Pre-market Movers: U, ELBM, RCUS, EVEX, INO… (RTTNews)
10.05.22	Inovio Pharmaceuticals Inc. Q1 Loss increases, misses estimates (RTTNews)
09.05.22	Pre-market Movers: DPSI, UDMY, ISPO, MAPS, LLNW… (RTTNews)
02.03.22	Pre-market Movers: JWN, KPTI, BORR, SOFI, HOOK… (RTTNews)
01.03.22	Inovio Pharmaceuticals Inc. Q4 Loss increases, misses estimates (RTTNews)
14.12.21	INOVIO Issues Updates For VGX-3100; Long-term Data Favorable From REVEAL1 (RTTNews)
30.11.21	INOVIO To Test Its COVID-19 Vaccine Candidates Against Omicron Variant - Quick Facts (RTTNews)
09.11.21	Inovio Pharmaceuticals Inc. Q3 Earnings Summary (RTTNews)
09.11.21	Why INOVIO Is Rising In Pre-market? (RTTNews)
03.11.21	Inovio Gets Authorization For Phase 3 Trial Of INO-4800 COVID -19 Vaccine Candidate In India (RTTNews)
12.10.21	INOVIO Reports Homologous Boosting Data For COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
11.10.21	INOVIO Gets Approval To Conduct Phase 3 Trial Of COVID-19 DNA Vaccine Candidate,INO-4800 In Colombia (RTTNews)
09.08.21	EARNINGS SUMMARY: Details of Inovio Pharmaceuticals Inc. Q2 Earnings Report (RTTNews)
09.08.21	INOVIO Reports Second Quarter 2021 Financial Results (PR Newswire)
09.08.21	INOVIO Expands Partnership With Advaccine To Explore Heterologous Prime-boosting Using INO-4800 (RTTNews)
09.08.21	INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO's COVID-19 DNA Vaccine Candidate (PR Newswire)
04.08.21	INOVIO Doses First Participant In Phase 2 Trial For DNA Vaccine Against MERS (RTTNews)
04.08.21	INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease (PR Newswire)
26.07.21	INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021 (PR Newswire)
09.06.21	INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800 (PR Newswire)
08.06.21	Inovio, Advaccine To Conduct Phase 3 Trial Of COVID-19 DNA Vaccine Candidate (RTTNews)
08.06.21	INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

29.12.24		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
29.12.24		Roche-CEO bescheinigt Pharmakonzern gesundes Geschäft
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Börse Frankfurt: DAX zum Handelsende auf grünem Terrain
27.12.24		Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

29.12.24

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

29.12.24

Roche-CEO bescheinigt Pharmakonzern gesundes Geschäft

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Börse Frankfurt: DAX zum Handelsende auf grünem Terrain

27.12.24

Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Inovio Pharmaceuticals Inc

Aktien Top/Flop

Inovio Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten